Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 11.6M | 7.8M | 7.1M | 13.0M |
Selling general and admin | 1.9M | 927K | 777K | 2.0M |
Other operating expenses | — | — | — | — |
Operating income | -13.6M | -8.7M | -7.9M | -15.0M |
Non operating interest income | ||||
Income | 1.5M | 2.1M | 2.4M | 2.7M |
Expense | 88K | 204K | 203K | — |
Other income expense | 1.3M | -3.7M | 732K | -754K |
Pretax income | -10.9M | -10.5M | -5.0M | -13.0M |
Tax provision | 29K | -41K | 9K | -25K |
Net income | -10.9M | -10.5M | -5.0M | -13.0M |
Basic EPS | -0.4 | — | -0.2 | -0.4 |
Diluted EPS | -0.4 | — | -0.2 | -0.4 |
Basic average shares | 30.5M | — | 30.5M | 30.5M |
Diluted average shares | 30.5M | — | 30.5M | 30.5M |
EBITDA | -10.6M | -5.8M | -5.1M | -14.0M |
Net income from continuing op. | -10.9M | -10.5M | -5.0M | -13.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |